c19v.info.covid19vaccinen.se Open in urlscan Pro
212.18.224.194  Public Scan

Form analysis
0 forms found in the DOM

Text Content

TILLGÄNGLIGA DOKUMENT. GRATIS ATT LADDA NER.


 * Advanced Technology International (ATI) – Underlying contract to execute MCDC
   and COVID-19 contracts on behalf of the federal government.
   * DoD-ATI Other Transaction Authority Agreement W15QKN1691002-P00085. April
     8, 2016.
   * DoD-ATI Other Transaction Authority Agreement W15QKN1691002-P00085. April
     8, 2016. (Version obtained November 30, 2020 from HHS FOIA Reading Room)
 * Aerpio – respiratory condition treatment.
   * DOD-Aerpio Statement of Work W81XWH1590001.
   * DOD-Aerpio Project Approval Letter W81XWH1590001. July 28, 2020.
 * Altimmune – therapeutic.
   * DoD-Altimmune Project Approval Letter W81XWH159001. June 17, 2020.
   * DoD-Altimmune Statement of Work W81XWH159001.
   * DoD-Altimmune Revised Project Approval Letter (3) W81XWH159001. February 3,
     2021.
   * DoD-Altimmune Revised Project Approval Letter (2) W81XWH159001. December
     15, 2020.
 * America’s Blood Center – convalescent plasma.
   * HHS/ASPR/BARDA-America’s Blood Center Contract 75A50120000094 (includes
     Mods 1-8). April 17, 2020.
   * DOD-America’s Blood Centers Contract W911QY2190006. October 30, 2020.
 * ANP Technologies – diagnostics.
   * DoD-ANP Technologies Contract W911QY20D0019 (includes Mods 1-3). May 29,
     2020.
   * DOD-ANP Technologies Supply Order W911QY20D0019 (includes Mods 1-3). June
     2, 2020.
   * DOD-ANP Technologies Supply Order W911QY20P0141 (includes Mod 1). April 17,
     2020.
 * AstraZeneca – vaccine.
   * HHS/ASPR/BARDA-AstraZeneca Advanced Agreement to Other Transaction
     Authority Agreement 75A501-20-C-00114. May 20, 2020.
   * HHS/ASPR/BARDA-AstraZeneca Modification of OTA Agreement 75A501-20-C-00114
     MODP00001. July 31, 2020.
 * AstraZeneca – vaccine.
   * DoD-AstraZeneca Other Transaction Authority Agreement W15QKN2191003.
     October 28, 2020.
 * AstraZeneca – prophylactic monoclonal antibody.
   * DOD-AstraZeneca Contract W911QY2190001 (includes Mods 1, 2, 3, and 5).
     October 9, 2020.
 * AstraZeneca – therapeutic.
   * DoD-AstraZeneca Contract W911QY20C0119 (includes Mod 1). September 30,
     2020.
   * DoD-AstraZeneca Contract W911QY20C0119 (includes Mod 1). September 30,
     2020. (Version obtained by FOIA)
 * Atlantic Diving Supply – no-contact thermometers.
   * DOD-Atlantic Diving Supply Contract W911QY18D0019. September 16, 2020.
 * Beckman Coulter – diagnostic-related.
   * HHS/ASPR/BARDA-Beckman Coulter Contract 75A50119C00078. September 30, 2019.
   * HHS/ASPR/BARDA-Beckman Coulter Contract 75A50119C00078-P00001. May 15,
     2020.
   * HHS/ASPR/BARDA-Beckman Coulter Contract 75A50120C00189. September 28, 2020.
 * Biofire Defense – diagnostics.
   * DoD-Biofire Defense Supply Order W911QY13D0080 Contract W911QY20F0271.
     April 24, 2020.
   * DoD-Biofire Defense Supply Order W911QY13D0080 Contract W911QY20F0171
     (includes Mods 1-2). May 23, 2020.
   * DOD-Biofire Defense Supply Order W911QY20F0196 and W911QY20F0165 Contract
     W911QY13D0080 (includes Mod 1 of W911QY20F0196). April 17, 2020.
 * BCG Federal Corp – COVID-19-related support services.
   * DoD-BCG Federal Corp Contract W911QY20P0198. June 28, 2020.
 * Centivax – therapeutic.
   * DOD-Centivax Statement of Work W81XWH1590001.
   * DOD-Centivax Project Approval Letter W81XWH1590001. August 19, 2020.
 * Cepheid – test kits.
   * DoD-Cepheid Contract W911QY20C0046 (includes Mods 1, 2, 3, 5, and 6). April
     5, 2020.
   * DoD-Cepheid Contract W911QY20P0154 (includes Mods 1-6). April 27, 2020.
   * DoD-Cepheid Contract W911QY20P0195 (includes Mod 2). June 12, 2020.
   * DoD-Cepheid Technical Direction Letter W15QKN1691002. September 14, 2020.
   * DOD-Cepheid Contract W911QY20C0124 (includes Mods 1-5, Supply Order
     W911QY21F0116 (January 22, 2021) + 1 Mod, and Supply Order W911QY21F0205
     (March 25, 2021)). September 24, 2020.
 * ChemBio Diagnostic – antigen test.
   * HHS/ASPR/BARDA-ChemBio Diagnostic Contract 75A50120C00138. July 3, 2020.
   * HHS/ASPR/BARDA-ChemBio Diagnostic Contract 75A50120C00138-P00001. July 20,
     2020.
 * Controlant – services.
   * DoD-Controlant Contract W911QX21C0010 (includes Mods 1-4). November 25,
     2020.
   * DoD-Controlant Contract W911QX21C0010 Mods 5, 7, and 8. May 10, 2021.
 * Corning Incorporated – vaccine manufacturing supplies.
   * DoD-Corning Contract W911NF2030004. June 5, 2020.
 * Cue Health – diagnostics manufacturing supplies.
   * DoD-Cue Health Other Transaction Authority Agreement W911NF2190001. October
     13, 2020.
 * Cue Health – diagnostics.
   * HHS-Cue Health Contract HHSO100201800016C. June 4, 2018.
   * HHS-Cue Health Contract HHSO100201800016C-P00001. September 1, 2019.
   * HHS-Cue Health Contract HHSO100201800016C-P00002. March 21, 2020.
   * HHS-Cue Health Contract HHSO100201800016C-P00003. May 13, 2020.
   * HHS-Cue Health Contract HHSO100201800016C-P00004. September 22, 2020.
 * Culmen – PPE.
   * DOD-Culmen International Contract W911QY18D0042 (includes Mods 1-8). April
     22, 2020.
 * Cytiva (Global Life Sciences Solutions) – vaccine manufacturing supplies.
   * DoD-Cytiva Contract W911NF2130001 (includes Mod 1). October 13, 2020.
 * Cytovale – COVID-related sepsis assessment.
   * HHS-Cytovale Contract 75A50119C00072. September 28, 2019.
   * HHS-Cytovale Contract 75A50119C00072-P00001. April 7, 2020.
 * Diasorin – assays.
   * HHS/ASPR/BARDA-DiaSorin Contract 75A50120C00017. March 11, 2020.
 * Diomics Corporation – diagnostics.
   * DoD-Diomics Corporation Project Approval Letter W81XWH159001. August 17,
     2020.
   * DoD-Diomics Corporation Revised Project Approval Letter W81XWH159001.
     February 2, 2021.
   * DoD-Diomics Corporation Statement of Work W81XWH159001.
 * Eli Lilly – therapeutic.
   * DoD-Eli Lilly Contract W911QY21C0016 (includes Mods 1-5). October 27, 2020.
   * DOD-Eli Lilly Contract W911QY21D0012-P00002. April 7, 2021.
   * DOD-Eli Lilly Contract W911QY21F0167-P00003. May 27, 2021.
 * Emergent Biosolutions – convalescent plasma manufacturing and clinical
   studies.
   * DOD-Emergent Biosolutions Canada Contract W911QY2090013 (includes Mod 1).
     June 24, 2020.
 * Emergent Biosolutions – vaccine manufacturing.
   * HHS/ASPR/BARDA-Emergent Biosolutions Contract HHSO100201200004I. June 15,
     2012. (Version obtained via SEC filing)
   * HHS/ASPR/BARDA-Emergent Biosolutions Contract HHSO100201200004I -Task Order
     75A50120F33007. May 24, 2020. (Version obtained via SEC filing)
   * HHS/ASPR/BARDA-Emergent Biosolutions Contract HHSO100201200004I -Task Order
     75A50120F33007. May 24, 2020. (Version obtained via FOIA)
   * HHS/ASPR/BARDA-Emergent Biosolutions Contract
     HHSO100201200004I-75A50120F33007-P00001. August 24, 2020.
   * HHS/ASPR/BARDA-Emergent Biosolutions Contract
     HHSO100201200004I-75A50120F33007-P00002. May 13, 2020.
   * HHS/ASPR/BARDA-Emergent Biosolutions Contract
     HHSO100201200004I-75A50120F33007-P00003. October 7, 2020.
 * Emory University – therapeutic.
   * DoD (via ATI)–Emory University Technical Direction Letter Other Transaction
     Authority W15QKN1691002. July 1, 2020.
 * Empatica – diagnostics technology.
   * HHS/ASPR/BARDA-Empatica Contract 75A50120C00132. June 18, 2020.
 * Empatica – diagnostics technology.
   * DoD-Empatica Project Approval Letter W81XWH159001. September 10, 2020.
   * DoD-Empatica Statement of Work W81XWH159001.
 * Evidation Health – COVID-19 detection and forecasting model.
   * HHS/ASPR/BARDA-Evidation Health Contract 75A50120C00091. April 17, 2020.
 * Federal Resources Supply – collection kits.
   * DOD-Federal Resources Supply Contract W911QY18D0060 – Order W911QY20F0215
     (includes Mods 1-2). April 24, 2020.
   * DOD-Federal Resources Supply Contract W911QY18D0060 – Order W911QY20F0226
     (includes Mods 1-3). May 4, 2020.
   * DOD-Federal Resources Supply Contract W911QY18D0060 – Order W911SR20F0039
     (includes Mods 1-5). April 22, 2020.
 * Fitbit – diagnostics technology.
   * DoD-Fitbit Project Approval Letter W81XWH1590001. September 23, 2020.
   * DoD-Fitbit Statement of Work W81XWH1590001.
 * Flir – thermometers.
   * DOD-Flir Commercial Contract W911QY20P0149. April 22, 2020.
 * Fujifilm – therapeutic.
   * DoD (via ATI)–Fujifilm Project Approval Letter 2009COVID19006 under Other
     Transaction Authority Agreement W81XWH1590001. July 9, 2020.
   * DoD (via ATI)–Fujifilm Revised Project Approval Letter 2009COVID19006 under
     Other Transaction Authority Agreement W81XWH1590001. December 14, 2020.
   * DoD (via ATI)–Fujifilm Statement of Work 2009COVID19006 under Other
     Transaction Authority Agreement W81XWH1590001. December 14, 2020.
 * Genentech (Roche) -therapeutic.
   * HHS/ASPR/BARDA-Genentech Other Transaction Authority Agreement
     HHSO100201800036C. September 27, 2018.
   * HHS/ASPR/BARDA-Genentech Modification of OTA Agreement HHSO100201800036C.
     March 27, 2020.
 * GenMark Diagnostics – diagnostic.
   * HHS/ASPR/BARDA-GenMark Diagnostics Contract 75A50120C00022. March 20, 2020.
   * HHS/ASPR/BARDA-GenMark Diagnostics Contract 75A50120C00022-P00001. May 28,
     2020.
   * HHS/ASPR/BARDA-GenMark Diagnostics Contract 75A50120C00022-P00002. July 20,
     2020.
 * GlaxoSmithKline – vaccines.
   * DoD/ASPR/BARDA-GlaxoSmithKline Contract W15QKN20C0048. July 30, 2020.
     * DoD/ASPR/BARDA-GlaxoSmithKline Contract W15QKN20C0048-P00001. July 30,
       2020.
     * DoD/ASPR/BARDA-GlaxoSmithKline Contract W15QKN20C0048-P00002. September
       16, 2020
 * Global Life Sciences – vaccine supply manufacturing.
   * DOD-Global Life Sciences Solution Contract W911NF2130001 P00003. July 29,
     2021.
 * Golden Max – infusion pump kits.
   * DoD-Golden Max Contract W81XWH20D0057 (includes Mod 1). April 17, 2020.
 * Grifols Therapeutics – convalescent plasma.
   * DoD (via ATI)-Grifols Therapeutics Technical Direction Letter Other
     Transaction Authority Agreement W15QKN1691002. September 1, 2020.
 * Grand River Aseptic Manufacturing (GRAM) – vaccine and therapeutic
   manufacturing.
   * DoD-Grand River Aseptic Manufacturing (GRAM) Contract W3110Y2OCC086-P00003.
     August 4, 2020.
   * DoD-Grand River Aseptic Manufacturing (GRAM) Contract W3110Y2OCC086 – Mods
     3 and 1-5. August 4, 2020. (Version obtained via FOIA)
   * DoD-Grand River Aseptic Manufacturing (GRAM) Contract W3110Y2OCC086 Mods
     1-5. September 1, 2020.
 * Hologic – testing assays.
   * HHS/ASPR/BARDA-Hologic Contract 75A50120P00069. April 29, 2020.
   * HHS/ASPR/BARDA-Hologic Contract 75A50120P00100. August 7, 2020.
   * HHS/ASPR/BARDA-Hologic Contract 75A50120P00100-P00001. October 29, 2020.
 * Icon – clinical trials.
   * DoD-Icon Other Transaction Authority Agreement W911QY2090007 (includes Mods
     1 and 4). April 27, 2020.
 * IIT Research Institute – tech transfer for virus neutralization assay.
   * DOD-IIT Research Institute Contract W911QY21C0014. November 30, 2020.
 * Immunome – antibody-related (redactions).
   * DOD-Immunome Contract W911QY2090019. July 3, 2020.
 * Inbios International – diagnostics.
   * DoD-Inbios International Contract W81XWH20F0253 (includes Mod 1). June 15,
     2020.
 * Inbios – antibody diagnostic.
   * HHS-InBios Contract 75A50120C00090. April 26, 2020.
 * Inhalon Biopharma – inhaled prevention/therapeutic.
   * DoD-Inhalon Biopharma Project Approval Letter W81XWH1590001. September 11,
     2020.
   * DoD-Inhalon Biopharma Statement of Work W81XWH1590001.
 * Inovio Pharmaceuticals – vaccine delivery.
   * DoD-Inovio Pharmaceuticals Contract W911QY20C0084. June 18, 2020. (Version
     obtained from SEC filings)
   * DoD-Inovio Pharmaceuticals Contract W911QY20C0084. June 18, 2020. (Version
     obtained via FOIA request)
   * DoD-Inovio Pharmaceuticals Other Transaction Authority Agreement
     W911QY2090016. June 22, 2020. (Version obtained from SEC filings)
   * DOD-Inovio Pharmaceutical Other Transaction Authority Agreement
     W911QY2090016. June 22, 2020. (Version obtained via FOIA request)
 * Johns Hopkins University – clinical trials of convalescent plasma.
   * DOD-Johns Hopkins University Other Transactions Authority Agreement
     W911QY2090012 (includes Mod 5). June 8, 2020.
 * Johnson&Johnson (Janssen) – vaccine.
   * HHS/ASPR/BARDA-Janssen Other Transaction Authority Agreement
     HHSO100201700018C. August 15, 2017. (Version obtained by FOIA March 31,
     2021).
   * HHS/ASPR/BARDA-Janssen Amendment to OTA Agreement
     HHSO100201700018C-Amendment 6. February 11, 2020.
   * HHS/ASPR/BARDA-Janssen Amendment to OTA Agreement
     HHSO100201700018C-Amendment 6. February 11, 2020. (Version obtained by FOIA
     March 31, 2021).
   * HHS/ASPR/BARDA-Janssen Amendment to OTA Agreement
     HHSO100201700018C-Amendment 7. March 20, 2020.
   * HHS/ASPR/BARDA-Janssen Amendment to OTA Agreement
     HHSO100201700018C-Amendment 8. March 27, 2020.
   * HHS/ASPR/BARDA-Janssen Amendment to OTA Agreement
     HHSO100201700018C-Amendment 8. February 11, 2020. (Version obtained by FOIA
     March 31, 2021).
   * HHS/ASPR/BARDA-Janssen Amendment to OTA Agreement
     HHSO100201700018C-Amendments 1, 2, 3 (dates redacted) 4 (date not listed),
     5 (December 19, 2019), 9 (date not listed), 10 (August 21, 2020). (Version
     obtained by FOIA June 2021)
   * HHS/ASPR/BARDA-Janssen Amendment to OTA Agreement
     HHSO100201700018C-Amendment 6. February 11, 2020. (Version obtained by FOIA
     June 2021)
 * Johnson&Johnson (Janssen) – therapeutic.
   * HHS/ASPR/BARDA-Janssen Other Transaction Authority Agreement
     HHSO100201800012C. September 21, 2018.
   * HHS/ASPR/BARDA-Janssen Amendment to OTA Agreement
     HHSO100201800012C-Amendment 1. April 4, 2019.
   * HHS/ASPR/BARDA-Janssen Amendment to OTA Agreement
     HHSO100201800012C-Amendment 2. August 1, 2019.
   * HHS/ASPR/BARDA-Janssen Amendment to OTA Agreement
     HHSO100201800012C-Amendment 3. January 31, 2020.
   * HHS/ASPR/BARDA-Janssen Amendment to OTA Agreement
     HHSO100201800012C-Amendment 4. February 14, 2020.
   * HHS/ASPR/BARDA-Janssen Other Transaction Authority Agreement
     HHSO100201800012C. September 21, 2018. (Version obtained via FOIA June
     2021)
 * Johnson&Johnson (Janssen) – vaccine.
   * DoD (via ATI)-Janssen Other Transaction Authority Agreement
     W15QKN1691002-P00081. August 5, 2020.
   * DoD (via ATI)-Janssen Other Transaction Authority Agreement
     W15QKN1691002-P00081-Mod00001. September 21, 2020. (Version obtained by
     FOIA)
 * Just Evotec – therapeutic manufacturing.
   * DOD-Just Evotec Contract W911QY2090015 (includes Mods 1-3). July 7, 2020.
 * Kalman – labor support services.
   * DOD-Kalman W911QY19F0147-P00042. March 1, 2021.
 * KPMG – prototype process for mAb infusion capacity.
   * DOD-KPMG W912CG2190001-P00001. June 16, 2021.
 * Lumen Bioscience – therapeutic.
   * DoD-Lumen Bioscience Project Approval Letter W81XWH1590001. July 24, 2020.
   * DoD-Lumen Bioscience Revised Project Approval Letter (2) W81XWH1590001.
     August 11, 2020.
   * DoD-Lumen Bioscience Revised Project Approval Letter (3) W81XWH1590001.
     December 9, 2020.
   * DoD-Lumen Bioscience Revised Project Approval Letter (4) W81XWH1590001.
     February 4, 2021.
   * DoD-Lumen Bioscience Statement of Work W81XWH1590001.
 * Luminex – antibody assay.
   * HHS/ASPR/BARDA-Luminex Contract 75A50120C00179. September 23, 2020.
   * HHS/ASPR/BARDA-Luminex Contract 75A5012C00037. March 26, 2020.
   * HHS/ASPR/BARDA-Luminex Contract 75A50120C00043. March 27, 2020.
 * Maxim – diagnostics.
   * DoD-Maxim Contract W911QY20D0018 (includes Mods 1-4). May 11, 2020.
 * MBio – antibody diagnostic.
   * HHS-MBio Diagnostics Contract 75A50120C00130. June 17, 2020.
 * Merck Sharp & Dohme – vaccine.
   * (Note: HHSO100201600031C began as a contract to Bioprotection Systems for
     an Ebola vaccine, Merck entered into a collaboration agreement with BPS in
     2014)
   * HHS/ASPR/BARDA–Bioprotection Systems Corporation Contract
     HHSO100201600031C. September 29, 2016.
   * HHS/ASPR/BARDA–Bioprotection Systems Corporation Contract
     HHSO100201600031C-Attachment 2-Milestones. May 19, 2017.
   * HHS/ASPR/BARDA–Bioprotection Systems Corporation Contract
     HHSO100201600031C-Attachment 1-Statement of Work. May 19, 2017.
   * HHS/ASPR/BARDA–Bioprotection Systems Corporation Contract
     HHSO100201600031C-P00001. April 27, 2017.
   * HHS/ASPR/BARDA–Bioprotection Systems Corporation Contract
     HHSO100201600031C-P00002. September 6, 2017.
   * HHS/ASPR/BARDA–Bioprotection Systems Corporation Contract
     HHSO100201600031C-P00003. May 23, 2018.
   * HHS/ASPR/BARDA-Merck Sharp & Dohme Contract Amendment
     HHSO100201600031C-P00004. May 9, 2019.
   * HHS/ASPR/BARDA-Merck Sharp & Dohme Contract Amendment
     HHSO100201600031C-P00005. April 14, 2020. (Version obtained March 2021 via
     FOIA lawsuit)
   * HHS/ASPR/BARDA-Merck Sharp & Dohme Contract Amendment
     HHSO100201600031C-P00005. April 14, 2020.
 * Merck Sharp & Dohme – therapeutic.
   * DoD-Merck Sharp & Dohme Other Transaction Authority Agreement
     W911QY2190001. December 2, 2020.
 * Merck Sharp & Dohme – therapeutic.
   * DOD-Merck Sharp & Dohme Contract W911QY21C0031. June 7, 2021.
 * Microbiologics – tech transfer for virus neutralization assay.
   * DOD-Microbiologics Contract W911QY21C0012 (includes Mod 1). November 9,
     2020.
 * Minnesota Medical Warehouse – hand sanitizer.
   * DOD-Minnesota Medical Warehouse Contract W911SR20P0010 (includes Mods 1-3).
     April 30, 2020.
 * Moderna – vaccine.
   * HHS/ASPR/BARDA-Moderna Contract 75A50120C00034. April 16, 2020.
   * HHS/ASPR/BARDA-Moderna Contract 75A50120C00034. April 16, 2020. (Less
     redacted version obtained via FOIA lawsuit on February 8, 2021)
   * HHS/ASPR/BARDA-Moderna Contract 75A50120C00034-P00003. July 25, 2020.
 * Moderna – vaccine manufacturing.
   * DoD/ASPR/BARDA-Moderna Contract W911QY20C0100. August 9, 2020. (Version
     obtained from Moderna SEC filings)
   * DoD/ASPR/BARDA-Moderna Contract W911QY20C0100. August 9, 2020. (Version
     obtained October 29, 2020 from HHS FOIA Reading Room)
   * DoD/ASPR/BARDA-Moderna Contract W911QY20C0100. August 9, 2020. (Version
     obtained November 9, 2020 from HHS FOIA Reading Room)
   * DoD/ASPR/BARDA-Moderna Contract W911QY20C0100-P00001. August 9, 2020.
   * DoD/ASPR/BARDA-Moderna Contract W911QY20C0100-P00002. September 11, 2020.
   * DoD/ASPR/BARDA-Moderna Contract W911QY20C0100-P00003. December 11, 2020.
   * DoD/ASPR/BARDA-Moderna Contract W911QY20C0100-P00004. February 11, 2021.
     (Obtained via FOIA)
   * DoD/ASPR/BARDA-Moderna Contract W911QY20C0100 – Mods 7-10. June 15, 2021.
 * MRI Global – mobile medical laboratories.
   * DOD-MRI Global Contract W911SR20F0054 – Mods 1-2. May 27, 2020.
 * Murtech – diagnostics.
   * DoD-Murtech Contract W911QY20D0017 (includes Mods 1-2). May 11, 2020.
 * Nanomix – antibody diagnostics.
   * HHS/ASPR/BARDA-Nanomix Contract 75A50120C00060. April 2, 2020.
   * HHS/ASPR/BARDA-Nanomix Contract 75A50120C00060-P00001. June 19, 2020.
   * HHS/ASPR/BARDA-Nanomix Contract 75A50120C00060-P00002. July 24, 2020.
 * New Horizons Diagnostics Corp. – diagnostic.
   * DOD (via ATI)-New Horizons Diagnostics Technical Direction Letter Other
     Transaction Authority Agreement W15QKN1691002 (includes updated TDL). May
     26, 2020.
 * Novavax – vaccine.
   * DoD-Novavax Contract W911QY20C0077 (includes Mod 1). June 4, 2020.
   * DoD-Novavax Contract W911QY20C0077 – Mods 1-4. June 4, 2020.
 * Novavax – vaccine.
   * DoD (via ATI)-Novavax Other Transaction Authority Agreement W15QKN1691002.
     June 25, 2020. (Version obtained via SEC filing)
   * DoD (via ATI)-Novavax Technical Direction Letter W15QKN1691002. July 6,
     2020. (Version obtained November 30, 2020 from HHS FOIA Reading Room)
   * DoD (via ATI)–Novavax Statement of Work W15QKN1691002. (Version obtained
     via FOIA lawsuit)
   * DoD (via ATI)–Novavax Technical Direction Letters and Statements of Work
     W15QKN1691002. July 6, 2020 and December 21, 2020. (Version obtained via
     FOIA lawsuit)
 * NOWDiagnostics – diagnostics.
   * HHS/ASPR/BARDA-NOWDiagnostics Contract 75A50120C00156. August 27, 2020.
 * Ology Bioservices (previously called Nanotherapeutics, Inc.) – vaccine
   manufacturing.
   * DoD-Ology Bioservices Other Transaction Authority Agreement-W911QY2090003
     Contract and Mods 1-5,8-10,12,14,15,17,23-25 . February 21, 2020
   * DoD-Ology Bioservices Other Transaction Authority Agreement
     OTA-W911QY2090003. February 21, 2020.
   * DoD-Ology Bioservices Other Transaction Authority Agreement Appendix
     OTA-W911QY2090003-Appendix-A-4. March 20, 2020.
   * DoD-Ology Bioservices Contract W911QY2090003-MOD-P00005. March 22, 2020.
 * Ology Bioservices (previously called Nanotherapeutics, Inc.) – vaccine
   manufacturing.
   * DoD-Ology Bioservices Contract W911QY20C0101 (includes Mod 1). August 17,
     2020.
 * Ophirex – therapeutic.
   * DoD-Ophirex Contract W81XWH20C0066 (includes Mods 1-3). June 19, 2020.
 * Orasure – rapid antigen test.
   * HHS/ASPR/BARDA-Orasure Contract 75A50120C00061. Date not listed.
   * HHS/ASPR/BARDA-Orasure Contract 75A50120C00122. May 27, 2020.
 * Ortho Clinical – antibody assays.
   * HHS/ASPR/BARDA-Ortho Clinical Contract 75A50120C00123. June 12, 2020.
   * HHS/ASPR/BARDA-Ortho Clinical Contract 75A50120C00123-P00001. August 28,
     2020.
   * HHS/ASPR/BARDA-Ortho Clinical Contract 75A50120P00103. September 18, 2020.
 * Oxford Nanopore Technologies – DNA sequencing.
   * DoD-Oxford Nanopore Technologies Contract W911QX20P0073 (includes Mod 1).
     April 22, 2020.
 * Partner Therapeutics, Inc. – therapeutic.
   * DOD (via ATI)-Partner Therapeutics Technical Direction Letter OTA
     W15QKN1691002. August 13, 2020.
 * Patricio Enterprises – COVID-19 mobile lab staffing.
   * DoD-Patricio Enterprises Supply Order W911QY2OF0270-P00001 Contract
     W911QY18D0251. June 3, 2020.
   * DOD-Patricio Enterprises Contract W911QY19F0133-P00037. December 7, 2020.
 * Pfizer – vaccine.
   * DoD (via ATI)-Pfizer Technical Direction Letter OTA W15QKN1691002. July 21,
     2020.
 * Pfizer – vaccines.
   * DoD-Pfizer Contract W15QKN21C0012 (includes Mod 310). December 22, 2020.
 * Pfizer – manufacturing.
   * DVA-Pfizer Contract V797D40269-P00376. June 1, 2021.
 * Pfizer – vaccine donation.
   * DoD-Pfizer Contract W58P0521C0002. July 30, 2021.
   * DOD-Pfizer Contract W58P0521C0002 Contract and P00376. July 30, 2021.
 * Pharm Olam – therapeutic clinical trial.
   * DOD-Pharm Olam Contract W911QY2190014. December 31, 2020.
 * Philips North America – diagnostics technology.
   * HHS/ASPR/BARDA-Philips North America Contract 75A50120C00097. May 7, 2020.
   * DoD-Philips North America Project Approval Letter W81XWH1590001. August 27,
     2020.
   * DoD-Philips North America Revised Project Approval Letter (2)
     W81XWH1590001. September 23, 2020.
   * DoD-Philips North America Revised Project Approval Letter (3)
     W81XWH1590001. October 13, 2020.
   * DoD-Philips North America Statement of Work W81XWH1590001.
 * Phlow Corporation – therapeutic.
   * HHS/ASPR/BARDA-Phlow Corporation Contract 75A50120000092. May 18, 2020.
 * Plasma Technologies – immune globulin hyperimmune manufacturing.
   * DOD-Plasma Technologies Contract W911QY2020004. August 14, 2020.
 * Protein Sciences Corporation (Sanofi) – vaccine.
   * HHS/ASPR/BARDA-Protein Sciences Corp Contract HHSO100201600005I. February
     14, 2020.
   * HHS/ASPR/BARDA-Protein Sciences Corp Contract HHSO100201600005I. August 16,
     2016.
 * Qiagen – diagnostic R&D.
   * HHS/ASPR/BARDA-Qiagen Contract 75A50120C00014. March 11, 2020.
 * Quidel – antigen assay R&D.
   * HHS/ASPR/BARDA-Quidel Contract 75A50120C00110. May 29, 2020.
 * Regeneron Pharmaceuticals – therapeutic.
   * HHS/ASPR/BARDA-Regeneron Other Transaction Authority Agreement
     HHSO100201700020C. September 21, 2017.
   * HHS/ASPR/BARDA-Regeneron Other Transaction Authority Agreement
     HHSO100201700020C-MOD0006. January 31, 2020.
   * HHS/ASPR/BARDA-Regeneron Other Transaction Authority Agreement
     HHSO100201700020C-MOD0006. (Date redacted).
   * HHS/ASPR/BARDA-Regeneron Contract HHSO100201700020C-MOD0002. April 22,
     2019.
   * HHS/ASPR/BARDA-Regeneron Contract HHSO100201700020C-MOD0003. May 18, 2019.
   * HHS/ASPR/BARDA-Regeneron Contract HHSO100201700020C-MOD0001. September 28,
     2018.
   * HHS/ASPR/BARDA-Regeneron Contract HHSO100201700020C-MOD0005. February 12,
     2020.
   * HHS/ASPR/BARDA-Regeneron Contract HHSO100201700020C MOD0008. June 15, 2020.
   * HHS/ASPR/BARDA-Regeneron Contract HHSO100201700020C MOD0009. June 19, 2020.
   * HHS/ASPR/BARDA-Regeneron Contract HHSO100201700020C MOD0007. April 29,
     2020.
 * Regeneron – therapeutic manufacturing.
   * DoD (via ATI)-Regeneron Other Transaction Authority Agreement W15QKN1691002
     (contract and Technical Direction Letter). July 6, 2020.
   * DoD (via ATI–Regeneron Technical Direction Letter W15QKN1691002. July 6,
     2020. (Version obtained November 30, 2020 from HHS FOIA Reading Room)
 * Regeneron – prophylactic monoclonal antibody.
   * DOD-Regeneron Pharmaceutical Contract W15QKN21C0014. January 12, 2021.
   * DOD-Regeneron Pharmaceutical Contract W15QKN21C0014-P00004. July 26, 2021.
 * Rigel Pharmaceuticals – therapeutic.
   * DOD-Rigel Pharmaceuticals Other Transaction Authority Agreement
     W911QY2190018. January 29, 2021.
   * DOD-Rigel Pharmaceuticals Other Transaction Authority Agreement
     W911QY2190018. January 29, 2021. (Version obtained via FOIA)
 * SAB Biotherapeutics – antibody diagnostic.
   * DOD (via ATI)-SAB Biotherapeutics Technical Direction Letter and Statement
     of Work – W15QKN1691002. April 18, 2020.
 * Sanofi – vaccine.
   * DOD (via ATI)-Sanofi Technical Direction Letter W15QKN1691002. July 30,
     2020. (Version obtained November 30, 2020 from HHS FOIA Reading Room)
   * DOD (via ATI)-Sanofi Technical Direction Letter and Statement of Work
     RPP20-11 MCDC2011-005. December 18, 2020.
 * Sempulse – diagnostics technology.
   * DoD-Sempulse Project Approval Letter W81XWH1590001. September 23, 2020.
   * DoD-Sempulse Statement of Work W81XWH1590001.
 * Sepsis Alliance – sepsis training.
   * HHS/ASPR/BARDA-Sepsis Alliance Contract HHSO100201900021C. January 19,
     2019.
   * HHS/ASPR/BARDA-Sepsis Alliance Contract HHSO100201900021C-P00001. June 6,
     2019.
   * HHS/ASPR/BARDA-Sepsis Alliance Contract HHSO100201900021C-P00002. May 7,
     2020.
 * Sibel – diagnostics technology.
   * DoD-Sibel Project Approval Letter W81XWH1590001. August 27, 2020.
   * DoD-Sibel Statement of Work W81XWH1590001.
 * Siemens – immunoassay R&D.
   * HHS/ASPR/BARDA-Siemens Contract 75A50120C00111. May 28, 2020.
   * HHS/ASPR/BARDA-Siemens Contract 75A50120C00111-P00001. August 20, 2020.
   * HHS/ASPR/BARDA-Siemens Contract 75A50120P00102. September 17, 2020.
 * SIO2 – domestic pharmaceutical vials.
   * DOD-SIO2 Medical Contract W911NF2030003 (includes Mods 1-3). June 5, 2020.
 * Sonica – diagnostics.
   * HHS/ASPR/BARDA-Sonica Contract 75A50119C00043. August 1, 2019.
   * HHS/ASPR/BARDA-Sonica Contract 75A50119C00043-P00001. February 3, 2020.
 * SourceAmerica – face coverings.
   * DoD-SourceAmerica Contract W911QY20C0047 (includes Mods 1-5). April 17,
     2020.
   * DoD-SourceAmerica Contract W911QY20C0047-P00006. November 10, 2020.
 * Tangen – assay.
   * HHS/ASPR/BARDA-Tangen Biosciences Contract 75A50120C00085. April 15, 2020.
 * Tasso – antibody test kits.
   * DoD-Tasso Serology Contract W911QY20P0158 (includes Mods 1-4). May 1, 2020.
     (Version obtained November 30, 2020 from HHS FOIA Reading Room)
   * DoD-Tasso Serology Contract W911QY20P0158-P00005 and P00006. December 3,
     2020. (Version obtained via FOIA)
 * Texas A&M University System – expansion of manufacturing capacity (CIADM
   related).
   * HHS/ASPR/BARDA-Texas A&M University System Contract
     HHSO100201200002I-75A50120F33002. July 23, 2020.
   * HHS/ASPR/BARDA-Texas A&M University System Contract
     HHSO100201200002I-75A50120F33002-P0001. August 27, 2020.
   * HHS/ASPR/BARDA-Texas A&M University System Contract
     HHSO100201200002I-75A50120F33002-P0002. October 9, 2020.
 * Ultran Group – treatment device.
   * DOD (via ATI)–Ultran Group Technical Direction Letter Other Transaction
     Authority Agreement W15QKN1691002. September 16, 2020.
   * DOD (via ATI)–Ultran Group Technical Direction Letter Other Transaction
     Authority Agreement W15QKN1691002. September 16, 2020. (Version obtained
     via FOIA)
 * University of California at San Francisco – diagnostics technology.
   * DoD-UC San Francisco Project Approval Letter W81XWH1590001. August 5, 2020.
   * DoD-UC-San Francisco Statement of Work and Milestone Payment Schedule
     W81XWH1590001.
 * University of Connecticut – vaccination technology.
   * HHS/ASPR/BARDA-University of Connecticut Contract 75A50120C00162. August
     16, 2020.
 * Vaxess – spike protein vaccine manufacturing.
   * HHS/ASPR/BARDA-Vaxess Technologies Contract 75A50120C00160. August 6, 2020.
 * Vectrus-safety glasses.
   * DOD-Vectrus Mission Solutions Contract W911QY18D0140 (includes Mod 1).
     April 22, 2020.
 * VelocityDX – diagnostics.
   * DoD-VelocityDX Contract W911QY20D0031. August 12, 2020.
   * DoD-VelocityDX Contract W911QY20D0031. August 12, 2020. (Version obtained
     via FOIA)
 * Visby – diagnostics.
   * DoD-Visby Medical Contract W911QY20C0110 (includes Mod 1). September 20,
     2020.
   * DoD-Visby Medical Contract W911QY20C0110 (includes Mod 1). September 20,
     2020. (Version obtained via FOIA)
 * VitalConnect – vital sign threshold settings for COVID-19 patients.
   * HHS/ASPR/BARDA-VitalConnect Contract 75A50120C00108. May 20, 2020.
   * HHS/ASPR/BARDA-VitalConnect Contract 75A50120C00108-P00001. May 20, 2020.
 * VxBiosciences – therapeutic.
   * DoD-VxBiosciences Project Approval Letter W81XWH1590001. July 9, 2020.
   * DoD-VxBiosciences Statement of Work W81XWH1590001.
 * Vyaire Medical, Inc. – ventilators.
   * HHS/ASPR/SNS-Vyaire Medical Contract 75A50120000049 (includes Mod 1). March
     31, 2020.
 * Waukesha Foundry – testing swabs.
   * DOD-Waukesha Foundry Contract W911SR20P0009 (includes Mods 1-4). April 17,
     2020.
 * World Enterprises – volatile organic compound detection.
   * DOD-World Enterprises W911SR21C0008 (includes Mods 1-3). November 13, 2020.
 * 98Point6 – COVID-related Smartphone technology.
   * HHS-98Point6 Contract 75A50120C001519. October 9, 2020.

US agreements not concerning COVID-19 research, but tied to related vaccine
technologies:

 * Moderna – Zika vaccine.
   * HHS/ASPR/BARDA-Moderna Contract HHS0100201600029C. September 1, 2016.

US Government licenses related to COVID-19:

 * NIH/NIAID-Geo Vax – vaccine primes/boosters.
   * NIAID-Geo Vax Nonexclusive Patent License Agreement and Biological
     Materials License. October 22, 2020.
 * NIH/NIAID-AbCellera Biologics – vaccines and therapeutics.
   * NIAID-AbCellera Patent License Agreement. May 4, 2020.


EUROPE

 * European Commission-AstraZeneca- vaccine.
   * European Commission-AstraZeneca Advance Purchase Agreement. August 27,
     2020.
 * European Commission-Curevac – vaccine.
   * European Commission-Curevac Advance Purchase Agreement.
 * European Commission-Sanofi Pasteur and GlaxoSmithKline – vaccines.
   * European Commission-Sanofi Pasteur and GlaxoSmithKline Advance Purchase
     Agreement. September 18, 2020.
 * European Investment Bank-BioNTech – financing vaccines.
   * European Investment Bank-BioNTech Finance Contract. June 10, 2020.
 * European Investment Bank-Curevac – financing vaccines.
   * European Investment Bank-Curevac Finance Contract. June 27, 2020.


AUSTRALIA

 * Australia-Novavax – vaccine.
   * Australia-Novavax Advanced Purchase Agreement. December 31, 2020.


BRAZIL

 * Fundação Oswaldo Cruz (Fiocruz)-AstraZeneca – vaccine.
   * Fiocruz-AstraZeneca Contract. September 8, 2020.


CANADA

 * Canada-Novavax – vaccine.
   * Canada-Novavax Advanced Purchase Agreement. January 19, 2021.


CHINA

 * Beijing Youfeng-Generex – vaccine.
   * NIVDCP-Beijing Youfeng-Generex Contract YF202011-A. November 13, 2020.


DOMINICAN REPUBLIC

 * Dominican Republic-Pfizer – vaccine.
   * Dominican Republic-Pfizer Vaccine Term Sheet. January 19, 2021.


ISRAEL

 * Israel Ministry of Health-Pfizer – vaccine.
   * Israel MOH-Pfizer Real-World Epidemiological Evidence Collaboration
     Agreement. January 6, 2021.


UNITED KINGDOM

 * United Kingdom-Novavax – vaccine.
   * United Kingdom-Novavax Supply Agreement. October 22, 2020.


INTER-COMPANY AGREEMENTS CONCERNING COVID-19

 * AIM Immuno Tech-Roswell Park Cancer Institute Corporation/Roswell Park
   Comprehensive Cancer Center – clinical trials.
   * Roswell Park Cancer Institute-AIM Immuno Tech Clinical Trial Agreement.
     July 6, 2020.
 * AIM Immuno Tech-Amarex – clinical trials.
   * AIM Immuno Tech-Amarex Project Work Order Proposal. August 4, 2020.
 * Amerimmune-Histogen – therapeutics.
   * Amerimmune-Histogen Collaborative Development and Commercialization
     Agreement. October 26, 2020.
 * Anixa Biosciences-OntoChem – therapeutics.
   * Anixa-OntoChem Collaboration Agreement. April 14, 2020.
 * AbCellera Biologics-Eli Lilly and Company – therapeutics.
   * AbCellera-Eli Lilly Research Collaboration and License Agreement. March 11,
     2020.
 * GlaxoSmithKline-Vir Biotechnologies – vaccines and therapeutics.
   * GlaxoSmithKline-Vir Preliminary Collaboration Agreement. April 5, 2020.
 * Hoth Therapetics-George Washington University – smartphone-based direct virus
   sensing system.
   * Hoth-GWU Sponsored Research Agreement. September 1, 2020.
 * Hoth Therapeutics-Voltron Therapeutics – vaccines.
   * Hoth-Voltron Development and Royalty Agreement. March [redacted], 2020.
 * Kiromic Biopharma-Molipharma – vaccine, therapeutics, and diagnostics.
   * Kiromic-Molipharma Joint Venture Agreement. April 2, 2020.
 * Moderna-Lonza – mRNA vaccines and therapeutics.
   * Moderna-Lonza Global Long Term Agreement. September 4, 2020.
 * Nascent Biotech-Manhattan Biosolutions – vaccines and therapeutics.
   * Nascent-Manhattan Research Collaboration Agreement. April 30, 2020.
 * Novavax-Serum Institute of India – vaccine.
   * Novavax-Serum Institute Supply and License Agreement. July 30, 2020.
 * PharmaCyte Biotech-Hai Kang Life Corporation Limited – diagnostic.
   * PharmaCyte-Hai Kang Life License Agreement. April 2, 2020.
 * Pfizer – BioNTech – vaccine.
   * Pfizer-BioNTech Collaboration Agreement. March 17, 2020.


ÖVRIGA AVTAL

 * EU Avtalet. Pfizer.
   * Ladda ner. Komplett, ej överstruket.

 * 159 studier, naturlig immunitet är bäst
   * Ladda ner. Med referenser.

 * EMA Dataläcka
   * Ladda ner

 * Colombia: Pfizer
   * Ladda ner. Komplett, ej överstruket.

 * Dominikanska Republiken: Pfizer
   * Ladda ner. Komplett, ej överstruket.

 * USA, Armen: Pfizer. Demo.
   * Ladda ner. Överstruket.

 * Peru: Pfizer.
   * Ladda ner. Komplett, ej överstruket.

 * Brasilien: Pfizer.
   * Ladda ner. Komplett, ej överstruket.

 * Albanien: Pfizer.
   * Ladda ner. Komplett.

TILLBAKA TILL COVID19VACCINEN.SE

Gå Upp

Skapad av covid19vaccinen.se